Quotient Sciences

Quotient Sciences is a contract research, development, and manufacturing organization (CRDMO) that describes itself as providing integrated solutions across contract research, manufacturing, and development, from early phase development through to commercial drug manufacturing. The company states it has worked with customers as a trusted partner providing contract research and contract manufacturing expertise across all stages of small molecule and synthetic peptide drug development for the last 35+ years. Its flagship platform, Translational Pharmaceutics®, integrates clinical activities with real-time cGMP drug product manufacturing. Quotient Sciences reports clinical testing and drug product manufacturing facilities in the UK and US, inspected and approved by leading global regulatory authorities, and says it supports both emerging biotechs and Fortune 100-ranked global pharma companies.

Quotient Sciences states that it has worked with customers as a trusted partner, providing contract research and contract manufacturing expertise across all stages of small molecule and synthetic peptide drug development for the last 35+ years. It describes itself as having over 30 years of CRDMO drug development expertise and a 35+ year history of excellence, bringing decades of integrated CRDMO experience covering drug product formulation development for Phase 1 trials through commercial drug product manufacturing. The company reports that its multidisciplinary teams have worked with thousands of molecules, helping clients move programs forward from early development and Phase I clinical testing through later stage clinical trials and commercial drug product manufacturing. It also states that it has clinical testing and drug product manufacturing facilities in the UK and US, inspected and approved by leading global regulatory authorities.

A CRDMO positioning itself as an integrated drug development partner and accelerator, with the mission "Molecule to cure. Fast."

• Drug Product Development & Manufacturing

  Experienced formulation development, clinical manufacturing, and sustained commercial production of your product.

• Early Clinical Development

  Integrated first-in-human and clinical pharmacology programs that help you make critical decisions earlier.

• Translational Pharmaceutics® Integrated Drug Development

  A unique approach to drug development, integrating clinical activities with real-time cGMP drug product manufacturing.

• 2019.10.22

  Reported2019.10.22

  Quotient Sciences appoints Claes Glassell as non-executive chairman[4]Quotient Sciences任命Claes Glassell为非执行董事长finanznachrichten.de

  Quotient Sciences announced the appointment of Claes Glassell as non-executive chairman of its board of directors.

Read more

1. 1Quotient Sciences | Pharmaceutical CRDMO, Small Molecule Drug Development, Phase 1 Clinical Trials, Drug Manufacturing, Clinical Research | Molecule to cure. Fast. | quotientscien…quotientsciences.com
2. 2About Us | What We Do | Quotient Sciencesquotientsciences.com
3. 3Quotient Sciences CRDMO: Accelerate drug development, integrated services for contract research, development, manufacturing (CRDMO) | Quotient Sciencesquotientsciences.com
4. 4Quotient Sciences任命Claes Glassell为非执行董事长finanznachrichten.de